3rd Circ. Urged To Revive Fosamax MDL
By Emily Field · May 24, 2023, 6:56 PM EDT
Fosamax patients have told the Third Circuit a lower court's decision to toss multidistrict litigation alleging Merck failed to warn of the osteoporosis drug's atypical femoral fracture risk is "riddled with...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login